Mylan, Pfizer settle patent suit on generic Detrol LA
(Reuters) - Mylan Inc said it settled with Pfizer Inc a lawsuit that accused it of infringing patents on overactive bladder drug Detrol LA.
Mylan can start selling its generic versions of Pfizer's drug from January 1, 2014, or earlier under some limited circumstances, but not after March 1, 2014, if the U.S. Food and Drug Administration approves.
Terms of the settlement are subject to review by the Federal Trade Commission and the U.S. Department of Justice, and other details are confidential, Mylan said.
The settlement with Mylan comes days after Pfizer resolved a similar dispute with Impax Laboratories Inc late last month.
(Reporting by Zeba Siddiqui in Bangalore; Editing by Akshay Lodaya)
- Tweet this
- Share this
- Digg this
- Netanyahu vows to complete Gaza tunnels destruction
- China should set lower 2015 GDP growth target of 6.5-7 pct - IMF
- U.S. says hopeful of WTO deal with India only hours before deadline
- UPDATE 2-Argentina defaults but investors see deal possible eventually
- Cricket - India four down and facing England defeat
The United States said on Thursday it was hopeful that differences between India and much of the rest of the world over a major trade agreement could be resolved in time, with only hours remaining before the deal has to be signed. Full Article
ONGC, Oil India bid $1.5 bln for stake in Murphy Oil's Malaysia assets - sources Full Article